Stanford has a coronavirus therapy that might prevent severe cases

$%name Stanford has a coronavirus therapy that might prevent severe cases by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

Researchers at Stanford have a new coronavirus treatment idea: Giving patients who have been just diagnosed COVID-19 positive an interferon drug version within three days of the test.
The trial is seeking 120 volunteers who haven’t been admitted to a hospital after their positive diagnosis. They will be given either the drug or a placebo, and then they’ll be monitored over nine successive visits.
If successful, such protocols could speed up recovery and reduce the risk of life-threatening complications for patients who are healing at home.
Visit BGR’s homepage for more stories.

Remdesivir became the first standard coronavirus drug following a study that showed the medicine can speed up recovery time. The drug isn’t a magical cure, however, and it won’t reduce the number of deaths. More research is required to see whether remdesivir can be paired up with other drugs to further improve the healing process and potentially reduce complications. The drug isn’t widely available though, and it will only be used in hospitals on some patients.

The race to find other treatments for COVID-19 is still on, and researchers aren’t only looking at vaccines. A team at Stanford has an idea that might prevent severe coronavirus cases, and that’s to start treating the disease with a specific drug as soon as the infection is confirmed.

Continue reading…

Today’s Top Deals

Trending Right Now:

Stanford has a coronavirus therapy that might prevent severe cases originally appeared on BGR.com on Mon, 11 May 2020 at 15:24:09 EDT. Please see our terms for use of feeds.